Skip to main content
profile image
Selected Works of Reshma Mahtani
Presentation
Efficacy and Safety of Talazoparib or Physician’s Choice of Chemotherapy in US Patients with HER2-negative Germline BRCA1/2 Mutated Locally Advanced/Metastatic Breast Cancer in the EMBRACA Study
Metastatic Breast Cancer Conference (2019)
  • Reshma Mahtani, Baptist Health South Florida
Abstract
S. Diab; H.S. Rugo; L.A. Mina; S. Puhalla; N.L. Henry; N. Denduluri; D. Yardley; Y. Wang; L. Shahied Arruda; I.C. Tudor; E. Gauthier. A, Czibere; J.K. Litton; S. Hurvitz
Disciplines
Publication Date
2019
Citation Information
Reshma Mahtani. "Efficacy and Safety of Talazoparib or Physician’s Choice of Chemotherapy in US Patients with HER2-negative Germline BRCA1/2 Mutated Locally Advanced/Metastatic Breast Cancer in the EMBRACA Study" Metastatic Breast Cancer Conference (2019)
Available at: http://works.bepress.com/reshma-mahtani/31/